Drug Approved to Help Young Patients Battle a Rare Cancer

MONDAY, Jan. 2, 2023 -- Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact.
The U.S. Food and Drug Administration has approved the immunotherapy drug atezolizumab (Tecentriq)...